+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma



A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma



Acta Oncologica 56(8): 1031-1042



Craniospinal irradiation (CSI) is the standard radiation therapy treatment for medulloblastoma. Conventional CSI photon therapy (Photon-CSI) delivers significant dose to surrounding normal tissue (NT). Research into pediatric CSI with proton therapy (Proton-CSI) has increased, with the aim of exploiting the potential to reduce NT dose and associated post-treatment complications. This review aims to compare treatment outcomes of pediatric medulloblastoma patients between Proton- and Photon-CSI treatments. A search and review of studies published between 1990 and 2016 comparing pediatric (2-18 years) medulloblastoma Proton- and Photon-CSI in three aspects - normal organ sparing and target coverage; normal organ dysfunction and second malignancy risks - was completed. Fifteen studies were selected for review and the results were directly compared. Proton-CSI reported improved out-of-field organ sparing while target coverage improvements were inconsistent. Normal organ dysfunction risks were predicted to be lower following Proton-CSI. Secondary malignancy risks (SMRs) were generally lower with Proton-CSI based on several different risk models. Proton-CSI conferred better treatment outcomes than Photon-CSI for pediatric medulloblastoma patients. This review serves to compare the current literature in the absence of long-term data from prospective studies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059398995

Download citation: RISBibTeXText

PMID: 28509599

DOI: 10.1080/0284186x.2017.1324207


Related references

Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiation Oncology 7: 116, 2012

Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatric Hematology and Oncology 35(4): 257-267, 2018

Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient. Physics in Medicine and Biology 58(4): 807-823, 2013

Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. International Journal of Radiation Oncology Biology Physics 81(3): 637-646, 2011

Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. International Journal of Radiation Oncology Biology Physics 86(2): 277-284, 2013

Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer Journal 10(6): 386-390, 2005

Reduced acute toxicity for adults with medulloblastoma treated with proton beam craniospinal irradiation. Strahlentherapie und Onkologie 190(1): 111-112, 2014

A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. RadioTherapy and Oncology 113(1): 84-88, 2014

Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment. Practical Radiation Oncology 7(6): E401-E408, 2017

Inter-Institutional Comparison of Personalized Risk Assessments for Second Malignant Neoplasms for a 13-Year-Old Girl Receiving Proton versus Photon Craniospinal Irradiation. Cancers 7(1): 407-426, 2015

Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma. Pediatric Blood and Cancer 65(8): E27095, 2018

Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma. Clinical and Translational Oncology 16(1): 96, 2014

Breast cancer screening for childhood cancer survivors after craniospinal irradiation with protons versus x-rays: a dosimetric analysis and review of the literature. Journal of Pediatric Hematology/Oncology 35(6): 462-467, 2013

Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma. International Journal of Radiation Oncology Biology Physics 103(3): 728-737, 2019

SU-E-T-257: Risk of Radiogenic Second Cancer after Photon and Proton Craniospinal Irradiation. Medical Physics 39(6part13): 3762-3962, 2012